MGRO MustGrow Biologics Corp.

0.2027USD0.2900 CAD · TSXV+5.45%Mkt Cap: 14.27M USDP/E: —

MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard plants. The company provides Biocontrol technolog…

Key Statistics

Company
Market Cap14.27M USD
Enterprise Value11.58M USD
Revenue (TTM)6.65M USD
Gross Profit818.45K USD
Net Income (TTM)-5.07M USD
Revenue/Share0.11 USD
Last Price0.2027 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryCA
SectorBasic Materials
IndustryAgricultural Inputs
ISINCA62822A1030
Valuation
P/E (Trailing)—
P/E (Forward)-14.50
PEG—
EV/EBITDA-3.88
EV/Revenue1.74
P/S2.15
P/B4.03
EPS (TTM)-0.06 USD
EPS (Forward)-0.01 USD
52W Range
0.19222% of range0.6571
52W High0.6571 USD
52W Low0.1922 USD
Profitability
Gross Margin14.13%
Oper. Margin-45.30%
EBITDA Margin-44.90%
Profit Margin-87.58%
ROE-837.00%
ROA-234.64%
ROIC-927.68%
ROCE-613.93%
Growth
Revenue Growth359.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.54M USD
CapEx (TTM)—
FCF Margin-21.85%
FCF Yield-10.18%
Net Debt-2.70M USD
Net Debt/EBITDA0.90
Net Debt/FCF—
Balance Sheet
Debt/Equity0.67
Current Ratio3.63
Quick Ratio2.94
Book Value/Sh0.05 USD
Cash/Share0.04 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)1.755 USD
Upside (mean)+765.5%
Target Range1.755 USD – 1.755 USD
# Analysts1
Ownership
Shares Out.70.40M
Float63.10M
Insiders9.18%
Institutions0.00%
Short Interest
Short Ratio0.1d
Short % Out.0.01%
Shares Short5.15K
Short (prev mo.)11.22K
Technical
SMA 500.2793 (-27.4%)
SMA 2000.3313 (-38.8%)
Beta0.39
S&P 52W Chg12.00%
Avg Vol (30d)58.76K
Avg Vol (10d)70.84K
Technical Indicators
RSI (14)34.9
MACD-0.0239
MACD Signal-0.0125
MACD Hist.-0.0114
BB Upper0.3164 USD
BB Middle0.2597 USD
BB Lower0.2030 USD
BB Width43.64%
ATR (14)0.0271 USD
Vol Ratio (20d)1.85x

About MustGrow Biologics (CVE: MGRO)

›

MustGrow Biologics (CVE: MGRO) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Agricultural Inputs industry, part of the Basic Materials sector.

The shares were at 0.2900 CAD on 19 November 2026, down 58.0% over 52 weeks. Its 52-week range is 0.2750 CAD to 0.9400 CAD: the price is 69.1% below the high and 5.5% above the low.

Its market capitalisation is 20.42M CAD.

MustGrow Biologics reports an operating margin of -45.3% and revenue up 359.7% year over year.

It holds more cash than debt, a net cash position of 3.86M CAD. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health. The next earnings report is expected on 2 December 2026.